CARDIOTOXICITY PHENOTYPES IN WOMEN TREATED WITH ANTHRACYCLINES AND TRASTUZUMAB FOR EARLY STAGE BREAST CANCER

被引：0
|
作者：
Nolan, Mark T. [1 ]
Selam, Mustafa Abdul [1 ]
Amir, Eitan [1 ]
Koch, Anne [1 ]
Yip, Paul [1 ]
Michalowska, Maria [1 ]
Wintersperger, Bernd [1 ]
Thavendiranathan, Paaladinesh [1 ]
机构：
[1] Peter Munk Cardiac Ctr, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)31406-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1186-557
引用
收藏
页码：799 / 799
页数：1
相关论文
共 50 条
  • [21] Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
    Mary Obasi
    Arielle Abovich
    Jacqueline B. Vo
    Yawen Gao
    Stefania I. Papatheodorou
    Anju Nohria
    Aarti Asnani
    Ann H. Partridge
    Cancer Causes & Control, 2021, 32 : 1395 - 1405
  • [22] Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
    Obasi, Mary
    Abovich, Arielle
    Vo, Jacqueline B.
    Gao, Yawen
    Papatheodorou, Stefania I.
    Nohria, Anju
    Asnani, Aarti
    Partridge, Ann H.
    CANCER CAUSES & CONTROL, 2021, 32 (12) : 1395 - 1405
  • [23] SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
    Icro Meattini
    Giuseppe Curigliano
    Francesca Terziani
    Carlotta Becherini
    Mario Airoldi
    Giacomo Allegrini
    Domenico Amoroso
    Sandro Barni
    Carmelo Bengala
    Valentina Guarneri
    Paolo Marchetti
    Francesca Martella
    Pierluigi Piovano
    Agnese Vannini
    Isacco Desideri
    Roberto Tarquini
    Giorgio Galanti
    Giuseppe Barletta
    Lorenzo Livi
    Medical Oncology, 2017, 34
  • [24] Early Increases in Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin, Taxanes, and Trastuzumab
    Putt, Mary
    Ky, Bonnie
    Sawaya, Heloisa
    French, Benjamin
    Januzzi, James L.
    Sebag, Igal
    Planas, Juan
    Cohen, Victor
    Blanchs, Jose
    Carver, Joseph
    Wiegers, Susan
    Martin, Randolph P.
    Picard, Michael
    Gerstzen, Robert
    Halpern, Elkan
    Passeri, Jonathan
    Irene, Kuter
    Scherrer-Crosbie, Marielle
    CIRCULATION, 2013, 128 (22)
  • [25] Trastuzumab related cardiotoxicity in breast cancer
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 371 - 372
  • [26] Trastuzumab Cardiotoxicity in Patients with Breast Cancer
    Freitas, Aguinaldo Figueiredo, Jr.
    Rassi, Salvador
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2014, 102 (02) : 200 - 200
  • [27] Risk Factors of Trastuzumab Related Cardiotoxicity in Taiwanese Breast Cancer Women
    Chien, Hsu-Chih
    Yang, Yea-Huei Kao
    Bai, Jane P. F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 283 - 284
  • [28] Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
    Guenancia, Charles
    Lefebvre, Annick
    Cardinale, Daniela
    Yu, Anthony F.
    Ladoire, Sylvain
    Ghiringhelli, Francois
    Zeller, Marianne
    Rochette, Luc
    Cottin, Yves
    Vergely, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3157 - +
  • [29] Adjuvant trastuzumab in women with breast cancer does not result in late cardiotoxicity
    Zerahn, B.
    Hasbak, P.
    Mortensen, C. E.
    Mathiesen, H. F.
    Andersson, M.
    Nielsen, D. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S185 - S185
  • [30] Relapse impact on overall survival in trastuzumab-treated women with HER2+early-stage breast cancer
    Gallagher, Christopher M.
    More, Kenneth
    Masaquel, Anthony
    Kamath, Tripthi
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Gauthier-Loiselle, Marjolaine
    Nitulescu, Roy
    Wu, Eric Qiong
    Sicignano, Nicholas
    Butts, Elizabeth
    Barnett, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345